Palo Alto’s Medicaid claims for COVID-19 services totaled $44,982 in 2024

Palo Alto recorded a minimum of $44,982 in Medicaid payments in 2024 for services billed under HCPCS codes specifically tied to COVID-19, based on figures from the U.S. Department of Health and Human Services Medicaid Provider Spending database.

Medicaid is a public health insurance initiative managed by state governments and funded collectively by federal and state sources. It provides coverage for low-income people, families, seniors, children, and individuals with disabilities, and remains a major component of the U.S. health care landscape.

Because Medicaid funding comes from taxpayers, fluctuations in local billing demonstrate how public health dollars are distributed within a community.

For this report, COVID-19–related services were identified using HCPCS codes categorized or described as “COVID-19” or “coronavirus” in either billing descriptions or reference material. Therefore, these numbers relate specifically to services explicitly tagged as COVID-related and omit pandemic care billed under more general or differently labeled medical codes.

By comparison, San Jose had the highest total in Medicaid claims related to COVID-19 services for any California city in 2024, at $5,601,479 in applicable claims.

In 2024, three providers in Palo Alto filed Medicaid claims for COVID-19–specific services. COVID-19 Vaccine Administration was the most commonly used code, making up $29,429 of the total.

On average, each Palo Alto provider received $14,994 in Medicaid payments for COVID-19–related services—less than the California average of $52,976 per provider for these services.

Total Medicaid payments in Palo Alto for all other categories rose by $3,811,985 between 2020 and 2024, an increase of 26.3% from earlier years.

Data from the Centers for Medicare & Medicaid Services indicates that joint federal and state spending on Medicaid was about $871.7 billion in the 2023 fiscal year. This made up approximately 18% of the nation’s total health expenditures, marking a significant rise from roughly $613.5 billion in 2019, prior to the onset of COVID-19.

This growth equates to about a 40% increase across several years, attributed mainly to expanded enrollment and greater usage of services during and after the pandemic.

Recent federal legislation under the Trump administration included major efforts to decrease federal Medicaid spending and reform the program structure. As an example, the “One Big Beautiful Bill Act,” adopted in 2025, is expected to reduce federal Medicaid outlays by more than $1 trillion over 10 years, while placing new requirements such as work mandates and higher cost-sharing, potentially limiting funding and coverage for certain recipients. Such measures are likely to shift more financial responsibility to states and constrain federal Medicaid growth, despite the program’s continued service to tens of millions nationwide.

Note: Includes only HCPCS codes directly labeled for COVID-19; figures do not cover all health care spending linked to the pandemic.

Details referenced in this article are from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The original source can be accessed here.